Immediate Impact
8 hit
Citing Papers
Antisense technology: A review
2021 Hit
Antisense technology: an overview and prospectus
2021 Hit
Works of George Tachas being referenced
A randomised, open-label, parallel group phase 2 study of antisense oligonucleotide therapy in acromegaly
2018
CD49d antisense drug ATL1102 reduces disease activity in patients with relapsing-remitting MS
2014